'Cutting Edge’ T-knife Gets €66m Series A Financing

To Fund Biotech’s Next-Generation Mouse-Based T-Cell Therapies

 
• By Sten Stovall
  
Mouse
T-knife will now advance its humanized mouse platform T-cell receptors in solid tumors • Source: Shutterstock

More from Clinical Trials

More from R&D